Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Seeks 25% of Sales From Emerging Markets by 2013
Bloomberg
Tuesday, November 9, 2010 - 8:05am
tags:
Merck, emerging markets
Tylenol Recalls Still Making Trouble for J&J
Seeking Alpha
Tuesday, November 9, 2010 - 8:04am
tags:
JNJ, Tylenol, recalls
J&J, Glaxo Drug-Safety Missteps Spark Congressional Probe of FDA Oversight
Bloomberg
Monday, November 8, 2010 - 5:26pm
tags:
GSK, JNJ, FDA, drug safety
Vivus narrows Q3 loss to $18M
Bizjournals.com
Monday, November 8, 2010 - 5:24pm
tags:
earnings, Vivus
Heartstopping News? More Multaq Safety Signals
Pharmalot
Monday, November 8, 2010 - 3:47pm
tags:
Multaq, Sanofi
What Genzyme’s CEO Doesn’t Know, and Doesn’t Want to Know, About Sanofi’s Hostile Bid
BNET Pharma
Monday, November 8, 2010 - 3:44pm
tags:
Henri Termeer, Sanofi, Genzyme, M&A
Sanofi Asks Genzyme to Keep Deal Path Open
NY Times, NY
Monday, November 8, 2010 - 3:42pm
tags:
Genzyme, Sanofi, M&A
PwC: Biotechs must adapt to survive in a harsh new world
Fierce Biotech
Monday, November 8, 2010 - 11:35am
tags:
biotech
Warner Chilcott 3Q profit drops despite purchases
Yahoo/AP
Monday, November 8, 2010 - 11:24am
tags:
Warner Chilcott, earnings
Vivus sells Muse assets for $23.5M
Bizjournals.com
Monday, November 8, 2010 - 10:51am
tags:
M&A, Muse, Vivus, Meda, erectile dysfunction
Allergan ($AGN) plots Botox promo for migraine use
Fierce Pharma
Monday, November 8, 2010 - 10:45am
tags:
migraines, Allergan, Botox
Boehringer Drug Lowers Bleeding Risk in Those Who Had Stroke
Bloomberg
Monday, November 8, 2010 - 10:43am
tags:
Boehringer Ingelheim, Pradaxa, blood thinners, stroke
When Is A Small Biotech Not Really So Small?
Pharmalot
Monday, November 8, 2010 - 10:42am
tags:
biotech, SIGA technologies, smallpox, HHS
King Pharma Disappoints
Yahoo/Zacks.com
Monday, November 8, 2010 - 10:41am
tags:
earnings, Pfizer, King
Dendreon's Dilemma Isn't Provenge Competition, Demand -- It's Geography
Minyanville
Monday, November 8, 2010 - 10:40am
tags:
Provenge, Dendreon, vaccines, prostate cancer
Abbott Labs: Strong Management, Balance Sheet, Growth and Dividends
Seeking Alpha
Monday, November 8, 2010 - 9:42am
tags:
Abbott Laboratories
Eli Lilly to buy Avid Radiopharmaceuticals
Marketwatch
Monday, November 8, 2010 - 9:40am
tags:
Avid, Eli Lilly, M&A
Cadence Pharma plans $85M public stock offering
Yahoo/AP
Monday, November 8, 2010 - 9:38am
tags:
Cadence Pharmaceuticals, stock offering
Amylin Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Seeking Alpha
Monday, November 8, 2010 - 9:37am
tags:
Amylin, earnings
Bayer implements new branding strategy
Pharma Times, UK
Monday, November 8, 2010 - 9:36am
tags:
Bayer, branding

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.